Neurological disorders and therapeutics targeted to surmount the blood&ndash;brain barrier

Código QR

Neurological disorders and therapeutics targeted to surmount the blood&ndash;brain barrier

Jagat R Kanwar, Bhasker Sriramoju, Rupinder K KanwarNanomedicine Laboratory of Immunology and Molecular Biomedical Research, Centre for Biotechnology and Interdisciplinary Biosciences, Institute for Frontier Materials (IFM), Deakin University, Waurn Ponds, Victoria, AustraliaAbstract: We are now in...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kanwar JR, Sriramoju B, Kanwar RK
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2012
Materias:	Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/5ffe1ee26bfe40eca32c8a61e53bef35
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Nanoformulated cell-penetrating survivin mutant and its dual actions
por: Sriramoju B, et al.
Publicado: (2014)

Blood&ndash;brain barrier: a real obstacle for therapeutics
por: Shiekh FA
Publicado: (2012)

Neurobehavioral burden of multiple sclerosis with nanotheranostics
por: Sriramoju B, et al.
Publicado: (2015)

Molecular targets in arthritis and recent trends in nanotherapy
por: Roy K, et al.
Publicado: (2015)

Oral administration of iron-saturated bovine lactoferrin–loaded ceramic nanocapsules for breast cancer therapy and influence on iron and calcium metabolism
por: Mahidhara G, et al.
Publicado: (2015)

Magnetic nanoformulation of azidothymidine 5&rsquo;-triphosphate for targeted delivery across the blood&ndash;brain barrier
por: Zainulabedin M Saiyed, et al.
Publicado: (2010)

Blood-Brain Barrier Dysfunction in CNS Disorders and Putative Therapeutic Targets: An Overview
por: Sabrina Rahman Archie, et al.
Publicado: (2021)

Comparison study of ferrofluid and powder iron oxide nanoparticle permeability across the blood&ndash;brain barrier
por: Hoff D, et al.
Publicado: (2013)

Oral administration of encapsulated bovine lactoferrin protein nanocapsules against intracellular parasite Toxoplasma gondii
por: An, et al.
Publicado: (2015)

Nanoscale drug delivery systems and the blood–brain barrier
por: Alyautdin R, et al.
Publicado: (2014)

Evaluation of the increase in permeability of the blood&ndash;brain barrier during tumor progression after pulsed focused ultrasound
por: Wong TT, et al.
Publicado: (2012)

Competitive inhibition of survivin using a cell-permeable recombinant protein induces cancer-specific apoptosis in colon cancer model
por: Roy K, et al.
Publicado: (2015)

Efficiency of drug delivery enhanced by acoustic pressure during blood&ndash;brain barrier disruption induced by focused ultrasound
por: Yang FY, et al.
Publicado: (2012)

Brain ischemia and ischemic blood&ndash;brain barrier as etiological factors in sporadic Alzheimer&rsquo;s disease
por: Ryszard Pluta, et al.
Publicado: (2008)

Enhanced permeability of blood–brain barrier and targeting function of brain via borneol-modified chemically solid lipid nanoparticle
por: Song H, et al.
Publicado: (2018)

Theranostic multimodular potential of zinc-doped ferrite-saturated metal-binding protein-loaded novel nanocapsules in cancers
por: Kamalapuram SK, et al.
Publicado: (2016)

Liposomes functionalized to overcome the blood–brain barrier and to target amyloid-β peptide: the chemical design affects the permeability across an in vitro model
por: Salvati E, et al.
Publicado: (2013)

Biodegradable Eri silk nanoparticles as a delivery vehicle for bovine lactoferrin against MDA-MB-231 and MCF-7 breast cancer cells
por: Roy K, et al.
Publicado: (2015)

Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier
por: Vieira DB, et al.
Publicado: (2016)

Postulated vasoactive neuropeptide immunopathology affecting the blood&ndash;brain/blood&ndash;spinal barrier in certain neuropsychiatric fatigue-related conditions: A role for phosphodiesterase inhibitors in treatment?
por: Sonya Marshall-Gradisnik, et al.
Publicado: (2008)

Encapsulated n-Butylidenephthalide Efficiently Crosses the Blood–Brain Barrier and Suppresses Growth of Glioblastoma
por: Lin YL, et al.
Publicado: (2020)

Microbubbles coupled to methotrexate-loaded liposomes for ultrasound-mediated delivery of methotrexate across the blood–brain barrier
por: Wang X, et al.
Publicado: (2014)

Quantification of transient increase of the blood–brain barrier permeability to macromolecules by optimized focused ultrasound combined with microbubbles
por: Shi L, et al.
Publicado: (2014)

Brain-targeting study of stearic acid&ndash;grafted chitosan micelle drug-delivery system
por: Xie YT, et al.
Publicado: (2012)

Characterization Of Blood–Brain Barrier Crossing And Tumor Homing Peptides By Molecular Dynamics Simulations
por: Arcangeli C, et al.
Publicado: (2019)

Novel microtubule-targeting agents &ndash; the epothilones
por: Daniel R Budman, et al.
Publicado: (2008)

Carbon Dots: A Future Blood–Brain Barrier Penetrating Nanomedicine and Drug Nanocarrier
por: Zhang W, et al.
Publicado: (2021)

Investigation of enzyme-sensitive lipid nanoparticles for delivery of siRNA to blood–brain barrier and glioma cells
por: Bruun J, et al.
Publicado: (2015)

Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood–brain barrier model
por: Shi D, et al.
Publicado: (2016)

Self-assembled biodegradable polymeric micelles to improve dapoxetine delivery across the blood–brain barrier
por: Abourehab MAS, et al.
Publicado: (2018)

Peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood–brain barrier in rats
por: Valiante S, et al.
Publicado: (2015)

Blood–brain barrier transport studies, aggregation, and molecular dynamics simulation of multiwalled carbon nanotube functionalized with fluorescein isothiocyanate
por: Shityakov S, et al.
Publicado: (2015)

Metastatic gastric cancer &ndash; focus on targeted therapies
por: Meza-Junco J, et al.
Publicado: (2012)

Overcoming the Blood–Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours
por: Ferraris C, et al.
Publicado: (2020)

Oral Administration of Encapsulated Bovine Lactoferrin Protein Nanocapsules Against Intracellular Parasite Toxoplasma gondii [Corrigendum]
por: Anand N, et al.
Publicado: (2020)

Nanocalcium-deficient hydroxyapatite&ndash;poly (&epsilon;-caprolactone)&ndash;polyethylene glycol&ndash;poly (&epsilon;-caprolactone) composite scaffolds
por: Wang Z, et al.
Publicado: (2012)

Oxcarbazepine-loaded polymeric nanoparticles: development and permeability studies across in vitro models of the blood–brain barrier and human placental trophoblast
por: Lopalco A, et al.
Publicado: (2015)

Magnetic field enhanced convective diffusion of iron oxide nanoparticles in an osmotically disrupted cell culture model of the blood–brain barrier
por: Sun Z, et al.
Publicado: (2014)

Brain Delivery of Curcumin Through Low-Intensity Ultrasound-Induced Blood–Brain Barrier Opening via Lipid-PLGA Nanobubbles
por: Yan Y, et al.
Publicado: (2021)

A dual-mediated liposomal drug delivery system targeting the brain: rational construction, integrity evaluation across the blood–brain barrier, and the transporting mechanism to glioma cells
por: Liu C, et al.
Publicado: (2017)